Showing results (111-120 of 244) with videos related to
Sort By:
Pageof 25
The American Journal of Gastroenterology|January 5, 2021
Sex Differences in Extrahepatic Outcomes After Antiviral Treatment for Hepatitis CJia Li, Stuart C Gordon, Yueren Zhou, et al.Journal of Community Health|April 1, 2014
Risk factors for hepatitis C infection among Vietnam era veterans versus nonveterans: results from the Chronic Hepatitis Cohort Study (CHeCS)Joseph A Boscarino, Alexandra Sitarik, Stuart C Gordon, et al.BMJ Open Gastroenterology|October 22, 2025
Assessment of adherence to guidelines for biochemical monitoring and ursodeoxycholic acid treatment response in a retrospective cohort of US patients with primary biliary cholangitisStuart C Gordon, Amandeep Sahota, Mark A Schmidt, et al.Journal of Viral Hepatitis|February 27, 2023
Prevalence of hepatitis B virus (HBV) and latent tuberculosis co-infection and risk of drug-induced liver injury across two large HBV cohorts in the United StatesRobert J Wong, Loralee Rupp, Mei Lu, et al.Journal of Vascular and Interventional Radiology : JVIR|December 24, 2005
Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survivalRiad Salem, Robert J Lewandowski, Bassel Atassi, et al.The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|January 10, 2024
Antiviral Treatment and Response are Associated With Lower Risk of Dementia Among Hepatitis C Virus-Infected PatientsMeng-Hua Tao, Stuart C Gordon, Trueman Wu, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 18, 2013
Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohortScott D Holmberg, Mei Lu, Loralee B Rupp, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 16, 2020
Mental and physical health status among chronic hepatitis B patientsYihe G Daida, Joseph A Boscarino, Anne C Moorman, et al.The American Journal of Managed Care|June 3, 2014
Hepatitis B virus infection testing and prevalence among Asian and Pacific IslandersVinutha Vijayadeva, Phillip R Spradling, Anne C Moorman, et al.Antiviral Therapy|September 13, 2005
A randomized, double-blind, placebo-controlled dose-escalation trial of merimepodib (VX-497) and interferon-alpha in previously untreated patients with chronic hepatitis CJohn G McHutchison, Mitchell L Shiffman, Ramsey C Cheung, et al.Pageof 25